Keyphrases
Age-related Risk
9%
Black Hispanic
18%
Bone Mineral Density
9%
Breast Cancer
10%
Breast Cancer Risk
27%
Chemotherapy
14%
Childhood Cancer Survivor Study
35%
Childhood Cancer Survivors
100%
Clinical Population
9%
COVID-19 Mortality
18%
COVID-19 Pandemic
18%
Forgoing
9%
Fracture Risk
9%
Genetic Architecture
9%
Genetic Risk
20%
Genome-wide Association Study
24%
Genome-wide Search
9%
Gonadotoxic Treatment
9%
Haplotype Association Analysis
9%
Hazard Ratio
14%
High Risk
16%
High-order Epistasis
9%
High-risk HPV
12%
Incidence Rate
10%
Insurance Disparities
9%
Late Mortality
9%
Long-term Survivors
21%
Lung
9%
Major Adverse Cardiovascular Events
9%
Medical Care
9%
Novel Locus
9%
Pattern Mining
9%
Polygenic Risk
10%
Polygenic Risk Score
27%
Primary Biliary Cholangitis
9%
Primary Ovarian Insufficiency
9%
Racial-ethnic
9%
Rare Genotypes
18%
Rare Pattern
9%
Risk Effects
11%
Risk Prediction Model
14%
Sex Therapy
9%
Single nucleotide Polymorphism
20%
Subsequent Malignancies
9%
Subsequent Malignant Neoplasms
17%
Survivors
56%
Treatment Effect
9%
Treatment-related
10%
U.S. Counties
18%
Zygosity
9%
Medicine and Dentistry
Cancer
9%
Cancer Diagnosis
7%
Cardiovascular System
9%
Chemotherapy
15%
Childhood Cancer
72%
Clinical Population
9%
Cohort Analysis
21%
Coronary Artery Disease
5%
COVID-19
9%
COVID-19 Mortality
9%
Emergency Department
9%
Flu Like Syndrome
9%
Genome Wide Association Study
19%
Germ Cell
9%
Hazard Ratio
9%
Lifespan
38%
Lung
9%
Malignant Neoplasm
21%
Medical Care
9%
Primary Ovarian Insufficiency
9%
Proportional Hazards Model
5%
Radiation Therapy
10%
Sex Therapy
9%
Single Nucleotide Polymorphism
13%
Virus Detection
9%
Biochemistry, Genetics and Molecular Biology
All Cause Mortality
9%
Allele
12%
Bone Density
9%
Cohort Study
16%
Early Menopause
9%
Gene Expression
6%
Genetic Architecture
9%
Genetic Risk
22%
Genetics
11%
Genome Wide Association Study
13%
Genome-Wide Association Study
25%
Germ Cell
21%
Germline
21%
Haplotype
36%
Lifespan
33%
Polygenic Score
14%
Population
6%
Single Nucleotide Polymorphism
8%
Single-Nucleotide Polymorphism
15%
Zygosity
9%